The magnitude and pattern of motor responses to single doses of subcutaneous apomorphine and oral levodopa were compared in 14 patients with Parkinson's disease. Although apomorphine produced much shorter motor responses than levodopa, the quality of response to the two drugs was virtually indistinguishable. These clinical observations support the notion that integrity of striatal post-synaptic dopamine receptors is a key determinant of responsiveness to dopaminergic treatment in Parkinson's disease.
The studies were performed early in the morning after all anti-Parkinsonian medication had been withheld overnight. On one day, an oral dose of levodopa 250 mg/carbidopa 25 mg was administered and on a second day, a subcutaneous injection of apomorphine. Mean apomorphine dose was 2 mg (1-4 mg), dose was determined in each case by doubling a previously established threshold dose for motor response. Studies were not necessarily performed on consecutive days. All patients were given domperidone 20 mg by mouth two hours before the apomorphine injection and remained fasting for the duration of the levodopa and apomorphine studies.
Motor function was assessed at five to 15 minute intervals following levodopa or apomorphine administration and continued until after the motor response had worn off, as judged by pre-dose baseline motor scores. The following assessment was performed as described previously:6 unilateral hand tapping count over 30 seconds, timed walking over a twelve metre distance (failure to complete the task within 30 seconds was recorded as 30 seconds) and scoring of severity of tremor according to a four point scale.
Dyskinetic involuntary movements were scored on a similar four point scale for each of six anatomical zones (each limb, craniocervical, trunk) giving a maximum dyskinesia score of 24. In addition, patients were scored in pre-dose "off" phases and at time of peak motor response using a modified Webster disability scale6 evaluation of twelve domains of Parkinsonian disability with a maximum disability score of 36. The amplitude of motor response was calculated for each motor parameter by subtracting pre-dose "off" motor score from the best score obtained during the subsequent "on" period.
Statistical significance was assessed by r=089 p<0001
Student's t test with comparison of paired data. Linear correlation coefficients were calculated to examine amplitude of motor response and "on" period motor scores for levodopa and apomorphine.
Results
All parameters of motor function showed close correlation between apomorphine and levodopa for both amplitude of motor response and best "on" period motor function. The mean amplitude of hand tapping count response was 18 for apomorphine and 20 for levodopa (r = 0-92, p < 0-001) and mean peak "on" phase tapping scores were 47 for apomorphine and 48 for levodopa (r = 0-89, p< 0-001) (fig 1) . Mean walking time response amplitude was -12 5s for apomorphine and -12 3s for levodopa (r = 0-81, p< 0-001) and mean best "on" walking time was 12 -ls for apomorphine and 11 s for levodopa (r = 0 80, p < 0-001). No patient had dyskinesia when "off" or tremor when "on", so amplitude and "on" scores for these motor parameters were the same. Mean apomorphine dyskinesia amplitude was 6-6 and mean levodopa dyskinesia amplitude was 7-0 (r = 0-92, p < 0-001). Mean apomorphine tremor amplitude was -0 9 and mean levodopa tremor amplitude was --1I (r = 0 90, p < 0 001). Mean modified Webster score amplitude was -14 2 for apomorphine and -14 7 for levodopa (r = 0-96, p < 0-001) and mean "on" phase Webster score was 6-9 for both drugs (r = 0 98, p < 0 001) (table 1) . There was no statistically significant difference in mean response amplitude or "on" phase scores between the two drugs for any motor parameter. 
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Not only was the overall magnitude of the response similar for apomorphine and levodopa, but both agents produced an almost identical pattern of response so far as the topography of motor deficits and dyskinesia in individual patients was concerned. The relative responsiveness of upper limbs (hand tapping) and gait function (walking time) in each case was the same for both drugs. One patient (Case 7) had a degree of drug resistant gait freezing which limited walking time improvement in "on" phases following both apomorphine and levodopa administration. Another patient (Case 2) usually had biphasic dyskinetic involuntary movements on oral levodopa medication. The single dose levodopa and apomorphine studies both showed a biphasic pattern of dyskinesia with similar topography and severity of involuntary movements.
Mean duration (range) of motor response to apomorphine injection was 56 minutes (30-80) compared with 211 minutes (140-315) for oral levodopa. Time to onset varied between three and 14 minutes (mean 7 9) for apomorphine and 19 and 75 minutes (mean 35A4) for levodopa. There was a weak correlation for duration of motor response for the two drugs (r = 0A45, p < 0-5) and none for time to onset of response (r = 0 16).
In 12 cases a transient deterioration in hand tapping performance to below pre-dose baseline level was observed following wearing off of motor response to both levodopa and apomorphine. Mean pre-dose to post-motor response tapping count ratio was 28 to 19 for levodopa (p < 0 01) and 29 to 22 for apomorphine (p < 0-001). 
Discussion

